C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease

Vascular and Endovascular Surgery

Volumn 42, Issue 4, 2008, Pages 341-347

  Hogh, Annette L ^a   Joensen, Jette ^b   Lindholt, Jes S ^a   Jacobsen, Martin R ^c   Ostergaard, Lars ^c  

^a VIBORG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atherosclerosis; C reactive protein; Cardiovascular deaths; Peripheral arterial disease; Prospective

Indexed keywords

C REACTIVE PROTEIN;

AMPUTATION; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; STROKE; THROMBOSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UP-REGULATION;

EID: 49649120506     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574408316138     Document Type: Article

References (31)

1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999 ; 138 (5, pt 2). 419S - 420S.
2. Lusis AJ Atherosclerosis. Nature. 2000 ; 407: 233-241.
3. Libby P., Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105: 1135-1143.
4. Glass CK, Witztum JL Atherosclerosis. the road ahead. Cell. 2001 ; 104: 503-516.
5. Zee RY, Ridker PM Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002 ; 162: 217-219.
6. Versaci F., Gaspardone A., Tomai F., Crea F., Chiariello L., Gioffre PA Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol. 2000 ; 85: 92-95, A8.
7. Schillinger M., Exner M., Mlekusch W., et al. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology. 2002 ; 224: 529-535.
8. Malouf JF, Kanagala R., Al Atawi FO, et al. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol. 2005 ; 46: 1284-1287.
9. Labarrere CA, Lee JB, Nelson DR, Al-Hassani M., Miller SJ, Pitts DE C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet. 2002 ; 360: 1462-1467.
10. Di NM, Schwaninger M., Cappelli R., et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP pooling project members. Stroke 2005 ; 36: 1316-1329.
11. deFilippi C., Wasserman S., Rosanio S., et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003 ; 290: 353-359.
12. Biasucci LM, Liuzzo G., Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999 ; 99: 855-860.
13. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 ; 279: 1477-1482.
14. Ridker PM, Cushman M., Stampfer MJ, Tracy RP, Hennekens CH Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998 ; 97: 425-428.
15. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 ; 285: 2481-2485.
16. Narins CR, Zareba W., Moss AJ, et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 2004 ; 164: 440-446.
17. Beckman JA, Preis O., Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005 ; 96: 1374-1378.
18. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 ; 107: 499-511.
19. Wildman RP, Muntner P., Chen J., Sutton-Tyrrell K., He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol. 2005 ; 96: 1579-1583.
20. Tzoulaki I., Murray GD, Lee AJ, Rumley A., Lowe GD, Fowkes FG C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh artery study. Circulation. 2005 ; 112: 976-983.
21. Aboyans V., Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation. 2006 ; 113: 2623-2629.
22. Shankar A., Li J., Nieto FJ, Klein BE, Klein R. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J. 2007 ; 154: 495-501.
23. Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350: 1387-1397.
24. Musicant SE, Taylor LM Jr, Peters D., et al. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. J Vasc Surg. 2006 ; 43: 772-780.
25. Ridker PM, Rifai N., Pfeffer MA, Sacks F., Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999 ; 100: 230-235.
26. Ridker PM, Rifai N., Rose L., Buring JE, Cook NR Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 ; 347: 1557-1565.
27. Ray KK, Cannon CP, Cairns R., et al. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005 ; 46: 1417-1424.
28. Albert MA, Danielson E., Rifai N., Ridker PM Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001 ; 286: 64-70.
29. Nielsen HW, Tuchsen F., Jensen MV Validity of the diagnosis essential hypertension in the National Patient Registry. Ugeskr Laeger. 1996 ; 158: 163-167.
30. Madsen M., Balling H., Eriksen LS The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry. Ugeskr Laeger. 1990 ; 152: 308-314.
31. Ebskov LB, Schroeder TV, Holstein PE Epidemiology of leg amputation: the influence of vascular surgery. Br J Surg. 1994 ; 81: 1600-1603.